Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study (Preprint)
Preprint
- 31 August 2021
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Febrile neutropenia is one of the most common oncologic emergencies and is associated with significant, preventable morbidity and mortality. Most patients who experience a febrile neutropenia episode are hospitalized, resulting in significant economic cost. OBJECTIVE This exploratory study implemented a remote monitoring system comprising a digital infrared thermometer and a pulse oximeter with the capability to notify providers in real time of abnormalities in vital signs that could suggest early clinical deterioration and thereby improve clinical outcomes. METHODS The remote monitoring system was implemented and compared to standard-of-care vital signs monitoring in hospitalized patients with underlying hematologic malignancies complicated by a febrile neutropenia episode in order to assess the feasibility and validity of the system. Statistical analysis was performed using the intraclass correlation coefficient (ICC) to assess the consistency between the measurements taken using traditional methods and those taken with the remote monitoring system for each of the vital sign parameters (temperature, heart rate, and oxygen saturation). A linear mixed-effects model with a random subject effect was used to estimate the variance components. Bland-Altman plots were created for the parameters to further delineate the direction of any occurring bias. RESULTS A total of 23 patients were enrolled in the study (mean age 56, SD 23-75 years; male patients: n=11, 47.8%). ICC analysis confirmed the high repeatability and accuracy of the heart rate assessment (ICC=0.856), acting as a supplement to remote temperature assessment. While the sensitivity and specificity for capturing tachycardia above a rate of 100 bpm were excellent (88% and 97%, respectively), the sensitivity of the remote monitoring system in capturing temperatures >37.8 °C and oxygen saturation <92% was 45% and 50%, respectively. CONCLUSIONS Overall, this novel approach using temperature, heart rate, and oxygen saturation assessments successfully provided real-time, clinically valuable feedback to providers. While temperature and oxygen saturation assessments lagged in terms of sensitivity compared to a standard in-hospital system, the heart rate assessment provided highly accurate complementary data. As a whole, the system provided additional information that can be applied to a clinically vulnerable population. By transitioning its application to high-risk patients in the outpatient setting, this system can help prevent additional use of health care services through early provider intervention and potentially improve outcomes.Keywords
All Related Versions
- Published version: JMIR Formative Research, 6 (1), e33265.
This publication has 19 references indexed in Scilit:
- Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical TrialsJCO Clinical Cancer Informatics, 2018
- Digital Health for Geriatric OncologyJCO Clinical Cancer Informatics, 2018
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update SummaryJournal of Oncology Practice, 2018
- Continuous Temperature Monitoring for Earlier Fever Detection in Neutropenic Patients: Patient's Acceptance and Comparison with Standard of CareTransplantation and Cellular Therapy, 2018
- Wearable activity monitors in oncology trials: Current use of an emerging technologyContemporary Clinical Trials, 2018
- Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012Journal of Oncology Practice, 2017
- ecancermedicalscience2016
- Low-cost indoor health monitoring system2016
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Risk of mortality in patients with cancer who experience febrile neutropeniaCancer, 2010